TLCM
ELV icon

Tiger Legatus Capital Management’s Elevance Health ELV Stock Holding History

Tiger Legatus Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-15,000
Closed -$4.53M – 14
2019
Q4 		$4.53M Buy
+15,000
New +$4.13M 1.88% 10
2019
Q3 		– Sell
-20,000
Closed -$5.64M – 13
2019
Q2 		$5.64M Sell
20,000
-10,000
-33% -$2.73M 2.51% 10
2019
Q1 		$8.61M Buy
+30,000
New +$8.68M 4.03% 6

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tiger Legatus Capital Management's ELV Position: Q1 2020 in Review

Tiger Legatus Capital Management sold out of Elevance Health (ELV) in Q1 2020, closing a stake of 15,000 shares — an estimated $4.53M sold.

Tiger Legatus Capital Management first reported a position in ELV in Q1 2019 and held it in 3 quarters. The position peaked at $8.61M in Q1 2019. 1,051 funds tracked by Wall St. Rank hold ELV as of Q1 2020.

  • Tiger Legatus Capital Management reported no remaining Elevance Health position as of Q1 2020 after selling out during the quarter.
  • Tiger Legatus Capital Management sold 15,000 Elevance Health shares in Q1 2020, an estimated $4.53M.
  • Tiger Legatus Capital Management first reported a position in Elevance Health in Q1 2019 and held it in 3 quarters.
  • Tiger Legatus Capital Management's Elevance Health position peaked at $8.61M in Q1 2019.
  • 1,051 funds tracked by Wall St. Rank held Elevance Health as of Q1 2020.

Based on Tiger Legatus Capital Management's 13F filing for Q1 2020, filed 15 May 2020.